Newly discovered role for Fas ligand in the cell-cycle arrest of CD4(+) T cells

Citation
J. Desbarats et al., Newly discovered role for Fas ligand in the cell-cycle arrest of CD4(+) T cells, NAT MED, 4(12), 1998, pp. 1377-1382
Citations number
41
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research General Topics
Journal title
NATURE MEDICINE
ISSN journal
10788956 → ACNP
Volume
4
Issue
12
Year of publication
1998
Pages
1377 - 1382
Database
ISI
SICI code
1078-8956(199812)4:12<1377:NDRFFL>2.0.ZU;2-#
Abstract
Fas Ligand (FasL) can induce apoptosis of Fas-bearing cells. It is expresse d on the cell surface of many tumor cells, immune-privileged tissues and ac tivated lymphocytes. We report here that Fast can itself transduce signals, leading to cell-cycle arrest and cell death in CD4(+) T cells. In vitro, F ast engagement inhibited CD4(+) T-cell proliferation, cell-cycle progressio n, and IL-2 secretion. In vivo, FasL engagement prevented superantigen-medi ated CD4(+), but not CD8(+), T-cell expansion. These findings demonstrate t hat FasL engagement regulates cell-cycle progression, and show that FasL en gagement in vivo has a potent anti-inflammatory effect specific for CD4(+) T cells.